DE-CSC
24.7.2018 17:02:05 CEST | Business Wire | Press release
CSC Security Center℠ is a first-of-its-kind online interface, designed to expose security blind spots that make vital online brand assets susceptible to cyber crime. Powered by advanced analytics built by CSC® to identify these risks, companies can take quick action to reduce real-world online threats that compromise web presence, customer data, and critical business functions, such as email.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180724005612/en/
CSC has been a leader in supporting brand owners for the past two decades—providing corporate domain name management, digital brand strategy, and administration of domain-related products such as domain name system (DNS), secure sockets layer (SSL) certificates, and new generic top-level domains (gTLDs).
“We understand the seemingly impossible job our clients face keeping their companies and brand assets safeguarded against internal and external security threats, and that the ability to conduct business is their top priority,” says CSC Digital Brand Services General Manager Mark Calandra. “Despite prevalent cyber crime, businesses often overlook the security of domain names, DNS, and SSL certificates. CSC Security Center gives our clients insight into—and easy control of—these important components of their online brands.”
CSC Security Center uses advanced proprietary algorithms to identify business-critical domains and ensure they are protected. This includes making sure domains are locked at the registry and registrar levels to prevent unauthorized changes, reviewing users and access levels for correct permissions, and checking that the right DNS hosting and SSL certificates are implemented in CSC client portfolios.
“The domain industry is no stranger to hackers and cyber criminals taking control and modifying or redirecting domain names, putting a company’s business, revenue, and reputation at risk,” says Calandra. “CSC Security Center is designed to not only tell our clients if they have a problem, but what they need to do to fix it. Our goal is to help our clients avoid these situations by providing them a single view into all these areas of risk.”
CSC partners with its clients to help tackle their most complex online brand challenges. CSC thrives on providing solutions that allow their clients to perform at their best.
“We are excited to introduce CSC Security Center to the market,” says Calandra. “It’s an essential companies won’t know they need until they see it. We believe this will redefine what domain management means.”
To find out more about how you can protect your blind spots and implement CSC Security Center, visit the website .
About CSC
CSC is a world leader of digital brand services headquartered in Wilmington, Delaware, and operating from offices throughout the U.S., Canada, Europe, and the Asia-Pacific region.
CSC helps businesses thrive online. We help effectively manage, promote, and secure our clients’ valuable brand assets against the threats of the online world. Leading companies around the world choose us to be their trusted partner, including more than 65% of the Interbrand® 100 Best Global Brands. Leveraging state-of-the-art technology, Digital Brand Services delivers outstanding outcomes through our unique account management structure. With our expert, dedicated team, you’ll have a daily point of contact to ensure your brand has the strength it needs to succeed in the 21st century. We help consolidate and secure, monitor and enforce, then optimize and promote your brands in order to maximize your digital presence, secure your digital intellectual property, and reduce costs.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180724005612/en/
Contact:
CSC
Laura Crozier
Public Relations Manager, USA
302-636-5401
x. 65526
Laura.Crozier@cscglobal.com
CSC
News Room
or
Letitia Thian
Marketing Manager, APAC
+65
6709 0104, x. 80104
Letitia.Thian@cscglobal.com
or
Marie
Le Maitre
Marketing Manager, EMEA
+44 (0)20 75132324
Marie.LeMaitre@cscglobal.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom